莫努匹韦/莫诺拉韦在中国能买到吗？

Can Monupivir/Monoravir be purchased in China?

Monupivir can treat infectious diseases caused by SARS-CoV-2 (people infected with the new coronavirus). It is currently available in China and has been launched for sale domestically on December 30, 2022. Monupivir, also known as monupivir/monapiravir, molnupiravir, and monogravir, is the third oral COVID-19 drug approved in China. Monupiravir/monabiravir (molnupiravir) is an oral small molecule novel coronavirus treatment drug. It received emergency use authorization from the U.S. Food and Drug Administration on December 23, 2021. It is used to treat adult patients with mild or moderate novel coronavirus infection who test positive for the novel coronavirus (SARS-CoV-2) and are at a higher risk of developing severe disease.

Patients can buy them at domestic hospital pharmacies, or obtain them through domestic professional overseas medical service institutions. Overseas drugs can be directly mailed to their homes from overseas. They are guaranteed to be genuine and at affordable prices. With a drug guarantee contract signed, patients are guaranteed to receive drugs.

Monupiravir/monoravir/molnupiravir (molnupiravir) is priced at US$700 per course in China, which is approximately RMB 4,700. The specification is 200mg per pill; 40 pills/bottle. In overseas markets, prices are not fixed due to exchange rate fluctuations. The current reference price is approximately 350 per box of molnupiravir, with specifications of 200 mg per pill and 40 pills per bottle. Patients can choose the version they want to use based on their own circumstances.

Monupiravir/molnupiravir is administered orally to patients over 18 years old, 800 mg (4 pills) each time, 2 times a day (8 pills), for 5 days. In other words, one box is enough for 5 days, and patients can also reserve several more boxes. For more details about monupivir/molnupiravir, you can consult customer service personnel.

Recommended related articles: